Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $4.2150 (0.72%) ($4.2150 - $4.2150) on Tue. Mar. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.61% (three month average) | RSI | 72 | Latest Price | $4.2150(0.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.5% a day on average for past five trading days. | Weekly Trend | AUTL advances 4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(71%) IBB(66%) XHB(56%) IBUY(55%) IWO(54%) | Factors Impacting AUTL price | AUTL will decline at least -1.805% in a week (0% probabilities). VIXM(-98%) TIP(-50%) EDOC(-37%) TLT(-26%) SHY(-21%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.805% (StdDev 3.61%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.27(-1.29%) | 10 Day Moving Average | $4.27(-1.29%) | 20 Day Moving Average | $4.04(4.33%) | To recent high | -22.8% | To recent low | 20.3% | Market Cap | $220m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |